Another example of a cell reprograming method in a PD model is the use of human adipose neural crest stem cells (haNCSCs) from subjects with PD and GBA1 mutation which is a gene linked to increased α-synuclein production (Yang et al., 2017). The gene discussed is GBA1; the disease is Parkinson disease.